Array
(
    [0] => Array
        (
            [acf_fc_layout] => text_editor_block
            [text_editor] => 

Making medicines affordable

in India
After nearly 10 years of operations, the Medicines Patent Pool (MPP) went to India to see first-hand how access to quality-assured generic medicines for HIV and hepatitis C has changed people’s life.
In the first of our impact series videos, patients, medical experts, governments, among others, explain how MPP’s work has generated impact. From saving lives to increased access, originators, generic manufacturers and committed partners have worked with MPP to deliver the best quality treatments to those who need them most.
Negotiating public-health driven licences with patent holders and sublicensing to generic manufacturers and product developers is the core work of the Medicines Patent Pool.





Click to see MPP’s work in licensing and supplying essential medicines in India:



 

Read our stories from India

            [text_editor_styles] => Array
                (
                    [alignment] => left
                    [text_colour_font] => text-default
                    [background_colour] => false
                    [background_image] => 
                    [background_image_style] => center / cover no-repeat
                    [overlay_colour] => false
                )

        )

    [1] => Array
        (
            [acf_fc_layout] => post_grid
            [show_latest_posts] => 
            [post_grid_layout] => rectangular
            [background_colour] => bg-pale-yellow
            [posts_per_row] => 3
            [posts_to_display_in_grid] => Array
                (
                    [0] => WP_Post Object
                        (
                            [ID] => 8896
                            [post_author] => 14
                            [post_date] => 2021-05-16 21:00:31
                            [post_date_gmt] => 2021-05-16 20:00:31
                            [post_content] => 


According to the World Health Organization, over six million people live with the hepatitis C virus in India. The National Viral Hepatitis Control Programme of India aims to put an end to the viral hepatitis epidemic by 2030. In this video, you’ll learn more on the situation from two different angles:

 	
In New Delhi, Simon Beddoe found out he had hepatitis C after an annual routine blood test. He tells us about his journey from his diagnostic to having access to his treatment.
 	
In Chandigarh, Professor Virendra Singh, Head of Hepatology at the Post Graduate Institute of Medical Education & Research (PGIMER), explains how having access to affordable direct-acting antivirals has dramatically changed the situation vis-à-vis the hepatitis epidemic in India.

The video was filmed in 2019 during a visit of the MPP team to India.
                            [post_title] => Fighting India’s silent epidemic - access to affordable and effective hepatitis C treatment
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => fighting-indias-silent-epidemic-access-to-affordable-and-effective-hepatitis-c-treatment
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2021-05-12 13:12:29
                            [post_modified_gmt] => 2021-05-12 12:12:29
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://medicinespatentpool.org/?post_type=stories&p=8896
                            [menu_order] => 0
                            [post_type] => stories
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [1] => WP_Post Object
                        (
                            [ID] => 8287
                            [post_author] => 14
                            [post_date] => 2021-01-22 09:38:01
                            [post_date_gmt] => 2021-01-22 09:38:01
                            [post_content] => 


Always wondered how a quality-assured generic medicine is being developed?
Ms Sivalakshmi, Head of Analytical Development at Laurus Labs, gives us an insight of the development process within the company. The Medicines Patent Pool partners with Laurus Labs and 21 other generic manufacturers to increase access to affordable quality-assured generic medicines in low- and middle-income countries. The video was filmed in 2019 during a visit of the MPP team to India.
                            [post_title] => The development of quality-assured generic medicines explained by Laurus Labs
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => the-development-of-quality-assured-generic-medicines-explained-by-laurus-labs
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2021-01-22 09:38:01
                            [post_modified_gmt] => 2021-01-22 09:38:01
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://medicinespatentpool.org/?post_type=stories&p=8287
                            [menu_order] => 0
                            [post_type] => stories
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                )

            [number_of_posts_to_show] => -1
            [post_type] => news-publications
            [disease_styles] => 
            [news_publication_type] => 
            [people_type] => 
            [company_type] => 
            [story_type] => 
            [include_filters] => 
            [show_images] => 1
            [show_events_from_date] => all
        )

)